198 Results

People

  1. Kelsen
    Kelsen
  2. Saltz
    Saltz
  3. Spriggs
    Spriggs
  4. Tong
    Tong
  5. Seidman
    Seidman
  6. Scher
    Scher
  7. Hudis
    Hudis
  8. Kemeny
    Kemeny
  9. Norton
    Norton
  10. Ilson
    Ilson

Groups

  1. Department of Medicine (112)
  2. Solid Tumor Oncology Division (99)
  3. Surgery (35)
  4. Gastrointestinal Oncology Service (33)
  5. Survivorship Research (27)
  6. Sloan Kettering Institute Faculty (26)
  7. Center for Pancreatic Cancer Research (24)
  8. Genitourinary Oncology Service (24)
  9. Molecular Pharmacology and Chemistry Program Faculty (24)
  10. Breast Medicine Service (23)
  1. "infusions, intravenous"
Formats
  1. Journal Article (192)
  2. Conference Paper (5)
  3. Meeting Abstract (1)
Groups
  1. Department of Medicine (112)
  2. Solid Tumor Oncology Division (99)
  3. Surgery (35)
  4. Gastrointestinal Oncology Service (33)
  5. Survivorship Research (27)
  6. Sloan Kettering Institute Faculty (26)

More Groups

People
  1. David Kelsen (16)
  2. Leonard Saltz (15)
  3. Nancy Kemeny (15)
  4. David Spriggs (14)
  5. William Tong (14)
  6. Andrew Seidman (13)

More People

Years
  1. 2023 (1)
  2. 2022 (1)
  3. 2021 (1)
  4. 2019 (1)
  5. 2018 (2)
  6. 2017 (1)

More Years

Publications
  1. Journal of Clinical Oncology (34)
  2. Cancer (23)
  3. Investigational New Drugs (15)
  4. Clinical Cancer Research (9)
  5. Gynecologic Oncology (8)
  6. Cancer Chemotherapy and Pharmacology (5)

More Publications

Publishers
  1. American Society of Clinical Oncology (34)
  2. Wiley Blackwell (28)
  3. Springer (26)
  4. Elsevier Inc. (23)
  5. Lippincott Williams & Wilkins (15)
  6. American Association for Cancer Research (14)

More Publishers

Results (198)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • One-hour paclitaxel via weekly infusion: Dose-density with enhanced therapeutic index
    Conference Paper

    Seidman, A. D.
    C M P Medica LLC * The Oncology Group (1998)

    Fulltext@MSK | Save
  • Dose-dense therapy with weekly 1-hour paclitaxel infusions in the treatment of metastatic breast cancer
    Journal Article

    Seidman, A. D.; Hudis, C. A.; Albanel, J.; Tong, W.; Tepler, I.; Currie, V.; Moynahan, M. E.; Theodoulou, M.; Gollub, M.; Baselga, J.; more...
    Journal of Clinical Oncology (1998)

    Fulltext@MSK | Save
  • Randomized, double-blind clinical trial of amphotericin B colloidal dispersion vs. amphotericin B in the empirical treatment of fever and neutropenia
    Journal Article

    White, M. H.; Bowden, R. A.; Sandler, E. S.; Graham, M. L.; Noskin, G. A.; Wingard, J. R.; Goldman, M.; Van Burik, J. A.; McCabe, A.; Lin, J. S.; more...
    Clinical Infectious Diseases (1998)

    Fulltext@MSK | Save
  • Supersaturating infusional humanized anti-CD33 monoclonal antibody HuM195 in myelogenous leukemia
    Journal Article

    Caron, P. C.; Dumont, L.; Scheinberg, D. A.
    Clinical Cancer Research (1998)

    Fulltext@MSK | Save
  • A phase II clinical trial of idarubicin administered to children with relapsed brain tumors
    Journal Article

    Arndt, C. A. S.; Krailo, M. D.; Steinherz, L.; Scheithauer, B.; Liu-Mares, W.; Reaman, G. H.
    Cancer (1998)

    Fulltext@MSK | Save
  • Phase II trial of topotecan administered as a 21-day continuous infusion in previously untreated patients with stage IIIB and IV non-small-cell lung cancer
    Journal Article

    Kindler, H. L.; Kris, M. G.; Smith, I. E.; Miller, V. A.; Grant, S. C.; Krebs, J. B.; Ross, G. A.; Slevin, M. L.
    American Journal of Clinical Oncology (1998)

    Fulltext@MSK | Save
  • Salvage weekly paclitaxel in recurrent ovarian cancer
    Journal Article

    Abu-Rustum, N. R.; Aghajanian, C.; Barakat, R. R.; Fennelly, D.; Shapiro, F.; Spriggs, D.
    Seminars in Oncology (1997)

    Fulltext@MSK | Save
  • Adjuvant therapy of colorectal cancer
    Journal Article

    Kemeny, N.; Saltz, L.; Cohen, A.
    Surgical Oncology Clinics of North America (1997)

    Fulltext@MSK | Save
  • A pilot clinical/pharmacological study of the protein kinase C-specific inhibitor safingol alone and in combination with doxorubicin
    Journal Article

    Schwartz, G. K.; Ward, D.; Saltz, L.; Casper, E. S.; Spiess, T.; Mullen, E.; Woodworth, J.; Venuti, R.; Zervos, P.; Storniolo, A. M.; more...
    Clinical Cancer Research (1997)

    Fulltext@MSK | Save
  • 9-Aminocamptothecin by 72-hour continuous intravenous infusion is inactive in the treatment of patients with 5-fluorouracil-refractory colorectal carcinoma
    Journal Article

    Saltz, L. B.; Kemeny, N. E.; Tong, W.; Harrison, J.; Berkery, R.; Kelsen, D. P.
    Cancer (1997)

    Fulltext@MSK | Save